删除或更新信息,请邮件至freekaoyan#163.com(#换成@)

Gene editing using CRISPR/Cas9: implications for dual-use and biosecurity

本站小编 Free考研考试/2022-01-02

Diane DiEuliis1,
James Giordano2,
1 Center for the Study of Weapons of Mass Destruction, National Defense University, Washington, DC 20057, USA;
2 Departments of Neurology and Biochemistry and Neuroethics Studies Program-Pellegrino Center for Clinical Bioethics, Georgetown University Medical Center, Washington, DC 20057, USA
Funds: by the European Union's Horizon 2020 Research and Innovation Programme under grant agreement 720270:HBP SGA1 (JG), and by federal funds UL1TR001409 from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, through the Clinical and Translational Science Awards Program (CTSA), a trademark of the Department of Health and Human Services, part of the Roadmap Initiative, "Re-Engineering the Clinical Research Enterprise (JG)".
This work was supported in part by funding from the AEHS Foundation, in conjunction with Project Neuro-HOPE (JG)






Abstract



PDF全文下载地址:

http://www.protein-cell.org/article/exportPdf?id=3c4e61dd-50ec-4a02-b572-e357f1e03d58&language=en
相关话题/editing using CRISPR